Research is uncovering novel mutations, epigenetic changes, and histological variations, driving the need for targeted therapies. Genomic instability is prevalent, and the tumor immune microenvironment is being…
biomolecules to enhance their therapeutic performance. These modifications allow nanocarriers to interact selectively with target cells or tissues, improve circulation time, evade immune clearance, and achieve…
reducing agents, such as glutathione, in cancer cells to trigger drug release, further enhancing targeting precision [4]. External stimuli, including light, ultrasound, and magnetic fields, provide additional control…